SEC 13F Intelligence

Consonance Capital Management LP / IOVA

Consonance Capital Management LP’s Iovance Biotherapeutics Inc Position

Does Consonance Capital Management LP own Iovance Biotherapeutics Inc (IOVA)? Not currently — the last reported position was 790.2K shares worth $25M in Q1 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$25M
Q1 2021
Shares
790.2K
% of Portfolio
+2.67%
Quarters Held
6
position exited

Position History IOVA

Reported value by quarter
Q1 ’19: $11MQ1 ’19Q2 ’19: $144MQ2 ’19Q3 ’19: $31MQ3 ’19Q4 ’19: $42MQ4 ’19Q4 ’20: $79MQ4 ’20Q1 ’21: $25MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2021790.2K$25M+2.67%
Q4 20201.71M$79M+7.41%
Q4 20191.51M$42M+2.55%
Q3 20191.68M$31M+3.02%
Q2 20195.85M$144M+10.16%
Q1 20191.14M$11M+0.68%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of IOVA.